default author photo

Ian Frank

University of Pennsylvania - Department of Medicine

Philadelphia, PA 19104

United States

SCHOLARLY PAPERS

2

DOWNLOADS

119

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Lower SARS-CoV-2-Specific Humoral Immunity in People Living With HIV-1 Recovered From Symptomatic Non-Hospitalized COVID-19

Number of pages: 44 Posted: 04 Jan 2022
affiliation not provided to SSRN, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University - School of Medicine, affiliation not provided to SSRN, Fred Hutchinson Cancer Research Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University, affiliation not provided to SSRN, Duke University - Duke Human Vaccine Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Pennsylvania - Department of Medicine, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology and affiliation not provided to SSRN
Downloads 96 (715,072)

Abstract:

Loading...

HIV-1, PLWH, People Living with HIV, SARS-CoV-2, COVID-19, humoral immunity, antibody, antibody isotype, antibody subclass, ACE-2 blocking, ADCP, antibody dependent phagocytosis, Multiplex assay, Meso Scale Discovery, IgG, IgG1, IgG3, IgA, CoVPN

2.

A Role for Nucleocapsid-Specific Antibody Function in COVID-19 Convalescent Plasma Therapy

Number of pages: 40 Posted: 08 Mar 2022
Harvard University - Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, Harvard University - Ragon Institute of MGH, MIT and Harvard, Harvard University - Ragon Institute of MGH, MIT and Harvard, Harvard University - Ragon Institute of MGH, MIT and Harvard, Harvard University - Ragon Institute of MGH, MIT and Harvard, Harvard University - Ragon Institute of MGH, MIT and Harvard, Harvard University - Ragon Institute of MGH, MIT and Harvard, University of Pennsylvania - Department of Medicine, University of Pennsylvania - Department of Pathology and Laboratory Medicine, University of Pennsylvania - Department of Medicine, University of Pennsylvania - Department of Biostatistics, Epidemiology, and Informatics, Kaiser Permanente Washington Health Research Institute, Yeshiva University - Division of Infectious Disease, Yeshiva University - Division of Infectious Disease, Ragon Institute of MGH, MIT and Harvard, University of Pennsylvania - Department of Medicine, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering and MassachusettsGeneral Hospital - Ragon Institute of MGH, MIT and Harvard
Downloads 23 (1,411,822)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Convalescent plasma, Functional antibodies, Fc modification, antibody glycosylation, antibody therapeutics, nucleocapsid, shifts in immunodominance, immunomodulation, COVID therapeutics